Literature DB >> 20498553

Clinical and imaging characteristics of Polyimplant Prosthesis hydrogel breast implants.

Jae Jeong Choi1, Jae Hee Lee, Bong Joo Kang, Sung Hun Kim, Ji Hye Lee, Sang Tae Ahn, Won Jun Yoon, Hong Ki Lee.   

Abstract

OBJECTIVE: To describe the clinical and imaging characteristics of Polyimplant Prosthesis (PIP) hydrogel breast implants.
METHODS: Seven patients with surgically confirmed 8 ruptured and 6 normal PIP hydrogel implants were enrolled in our study. We reviewed retrospectively the medical records and breast ultrasonographic and magnetic resonance imaging (MRI) findings of the patients.
RESULTS: Breast asymmetry was the most common clinical feature of PIP hydrogel implant rupture. The main radiologic finding of ruptured implants was a significant fluid collection around the implant. All 4 intracapsular ruptures showed no significant collapse of the implants despite a large accumulation of fluid surrounding the ruptured implants on ultrasonography and MRI. Three extracapsular ruptures showed variable collapse of the implants, partial collapse in 1 implant and total collapse in 2 implants. One extracapsular rupture showed enlargement of the implant. Ultrasonography and MRI revealed hydrogel extension to the muscles and chest wall in all 4 extracapsular ruptures and extensive inflammation and fibrosis in 3 extracapsular ruptures.
CONCLUSIONS: Polyimplant Prosthesis hydrogel implant rupture can be clinically silent. Knowledge of clinical and radiologic findings of the ruptured implants will be helpful in its diagnosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20498553     DOI: 10.1097/RCT.0b013e3181d0c751

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  1 in total

1.  Dual-energy CT for the evaluation of silicone breast implants.

Authors:  Thorsten R C Johnson; Isabelle Himsl; Karin Hellerhoff; Doris Mayr; Dorothea Rjosk-Dendorfer; Nina Ditsch; Bernhard Krauss; Klaus Friese; Maximilian F Reiser; Miriam S Lenhard
Journal:  Eur Radiol       Date:  2012-10-13       Impact factor: 5.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.